1

Obinutuzumab (GA101): A Comprehensive Overview

949142-50-1484431
Obinutuzumab, labeled as GA101, represents the novel monoclonal antibody designed for treat chronic lymphocytic leukemia. It targets this surface antigen expressed on B cells, leading to antibody-dependent https://www.targetmol.com/compound/obinutuzumab
Report this page

Comments

    HTML is allowed

Who Upvoted this Story